Prana Company Profile

23:13 EST 24th November 2015 | BioPortfolio



3275 Corporate View
United States of America


Phone: 760.566.1070
Fax: 760.566.1071

News Articles [8 Associated News Articles listed on BioPortfolio]

Orphan designation for Huntington's candidate

Drug development company Prana Biotechnology (ASX:PBT) today announced that the European Commission has approved orphan designation for its lead drug candidate, PBT2, for the treatment of Huntington...

Prana Biotechnology Limited (PBT) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Recently added to the BioPortfolio report store, Prana Biotechnology Limited (PBT) - Pharmaceuticals & Healthcare - Deals and Alliances Profile is a new report from GlobalData published on 2015-0...

Prana Reports FY15 Financial Results

Prana Biotechnology Limited (ASX:PBT) (NASDAQ:PRAN) yesterday announced its financial results for the 12 months to June 30, 2015. Financial Results ...

Prana Receives Non-Compliance Notice Regarding NASDAQ Minimum Bid Price Requirement

Prana Biotechnology Limited (ASX:PBT/NASDAQ:PRAN) has received notification from the Listing Qualifications Department of NASDAQ advising the Company that it is currently non-comp...

Prana Chief Scientific Advisor Receives Smithsonian American Ingenuity Award

Prana Biotechnology Limited (ASX:PBT/NASDAQ:PRAN) is pleased to congratulate its Chief Scientist, Professor Rudy Tanzi, who has been awarded a Smithsonian American Ingenuity Award...

Prana Announces Safety Outcomes of Alzheimer’s IMAGINE Extension Trial

Prana Biotechnology (ASX:PBT) (NASDAQ:PRAN) has today announced the safety outcomes of the IMAGINE Extension study in patients with Alzheimer’s disease. A 250mg...

Healthcare Technology Incubator MATTER Celebrates 100 Days of Accelerating Innovation

MATTER, the healthcare technology incubator for next-generation health IT, medical device, diagnostics and biopharma companies, has forged connections in its first 100 days that w...

European Commission Approves PBT2 Orphan Designation for Huntington’s Disease

Prana Biotechnology Limited (ASX:PBT/NASDAQ:PRAN) has today announced that the European Commission has approved orphan designation for PBT2 for the treatment of Huntington’s dis...

Drugs and Medications [0 Results]


PubMed Articles [0 Results]


Clinical Trials [0 Results]


Companies [3 Associated Companies listed on BioPortfolio]

Prana Biotechnology Limited

Prana Biotechnology was established to commercialise research into Alzheimer's disease and other major age-related neurodegenerative disorders. The Company was incorporated in 1997 and listed on the A...

Prana Biotechnology

Prana Biotechnology has developed a proprietary library of class-leading chemical compounds. This library is combined with a drug development program to explore novel therapeutics in multiple disease ...



More Information about "Prana" on BioPortfolio

We have published hundreds of Prana news stories on BioPortfolio along with dozens of Prana Clinical Trials and PubMed Articles about Prana for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Prana Companies in our database. You can also find out about relevant Prana Drugs and Medications on this site too.


Corporate Database Quicklinks

Searches Linking to this Company Record